@article{Harris_S-2022_182504,
title = {Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study},
author = {Harris, S. and Ruan, Y. and Wild, S. and Wargny, M. and Hadjadj, S. and Delasalle, B. and Saignes, M. and Ryder, R. and Field, B. and Narendran, P. and Zaccardi, F. and Wilmot, E. and Vlacho, B. and Llauradó, G. and Mauricio, D. and Nagi, D. and Patel, D. and Várnai, K. and Davies, J. and Gourdy, P. and Cariou, B. and Rea, R. and Khunti, K.},
month = {apr},
year = {2022},
abstract = {BACKGROUND &amp; AIMS: To assess the impact of pre-admission renin-angiotensin-aldosterone system inhibitor (RAASi) and statin use on mortality following COVID-19 hospitalization in adults with pre-existing diabetes.},
volume = {16},
issue = {5},
journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.dsx.2022.102484},
}
